Zvirblyte J, Nainys J, Juzenas S, Goda K, Kubiliute R, Dasevicius D, et al. Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotype. Commun Biol. 2024;7:780.
Google Scholar
Kowalewski A, Borowczak J, Maniewski M, Gostomczyk K, Grzanka D, Szylberg L. Targeting apoptosis in clear cell renal cell carcinoma. Biomed Pharmacother. 2024;175. 116805.
Google Scholar
Zhang J, Zhang Q. VHL and hypoxia signaling: beyond HIF in cancer. Biomedicines. 2018;6(1):35.
Ordóñez-Navadijo Á, Fuertes-Yebra E, Acosta-Iborra B, Balsa E, Elorza A, Aragonés J, et al. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma. Oncogene. 2016;35:587–94.
Google Scholar
Sourbier C, Srivastava G, Ghosh MC, Ghosh S, Yang Y, Gupta G, et al. Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma. Oncotarget. 2012;3:1472–82.
Google Scholar
Teisseire M, Giuliano S, Pagès G. Combination of anti-angiogenics and immunotherapies in renal cell carcinoma show their limits: targeting fibrosis to break through the glass ceiling? Biomedicines. 2024;12:385
Sharma R, Kadife E, Myers M, Kannourakis G, Prithviraj P, Ahmed N. Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. J Exp Clin Cancer Res. 2021;40:186.
Google Scholar
Sekino Y, Teishima J, Liang G, Hinata N. Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma. Int J Urol. 2022;29:1419–28.
Google Scholar
Abah MO, Ogenyi DO, Zhilenkova AV, Essogmo FE, Ngaha Tchawe YS, Uchendu IK, et al. Innovative therapies targeting drug-resistant biomarkers in metastatic clear cell renal cell carcinoma (ccRCC). Int J Mol Sci. 2024;26, 265
Yu M, Qian K, Wang G, Xiao Y, Zhu Y, Ju L. Histone methyltransferase SETD2: an epigenetic driver in clear cell renal cell carcinoma. Front Oncol. 2023;13:1114461.
Google Scholar
Zwelling LA. DNA topoisomerase II as a target of antineoplastic drug therapy. Cancer Metastasis Rev. 1985;4:263–76.
Google Scholar
Handa T, Kanke M, Takahashi TS, Nakagawa T, Masukata H. DNA polymerization-independent functions of DNA polymerase epsilon in assembly and progression of the replisome in fission yeast. Mol Biol Cell. 2012;23:3240–53.
Google Scholar
Vipat S, Gupta D, Jonchhe S, Anderspuk H, Rothenberg E, Moiseeva TN. The non-catalytic role of DNA polymerase epsilon in replication initiation in human cells. Nat Commun. 2022;13:7099.
Google Scholar
Zhu Y, Chen G, Song Y, Chen Z, Chen X. POLE2 knockdown reduce tumorigenesis in esophageal squamous cells. Cancer Cell Int. 2020;20:388.
Google Scholar
Zou W, Green DR. Beggars banquet: metabolism in the tumor immune microenvironment and cancer therapy. Cell Metab. 2023;35:1101–13.
Google Scholar
Zuo Q, Wu Y, Hu Y, Shao C, Liang Y, Chen L, et al. Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment. Heliyon. 2024;10:e30807.
Google Scholar
Zhu S, Luo Z, Li X, Han X, Shi S, Zhang T. Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications. J Cancer. 2021;12:54–64.
Google Scholar
Sadhukhan P, Seiwert TY. The role of macrophages in the tumor microenvironment and tumor metabolism. Semin Immunopathol. 2023;45:187–201.
Google Scholar
Han S, Wang W, Wang S, Yang T, Zhang G, Wang D, et al. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Theranostics. 2021;11:2892–916.
Google Scholar
Zou T, Gao S, Yu Z, Zhang F, Yao L, Xu M, et al. Salvianolic acid B inhibits RAW264.7 cell polarization towards the M1 phenotype by inhibiting NF-κB and Akt/mTOR pathway activation. Sci Rep. 2022;12:13857.
Google Scholar
Wang XL, Chen F, Shi H, Zhang M, Yan L, Pei XY, et al. Oxymatrine inhibits neuroinflammation byRegulating M1/M2 polarization in N9 microglia through the TLR4/NF-κB pathway. Int Immunopharmacol. 2021;100:108139.
Google Scholar
Zwart ES, van Ee T, Affandi AJ, Boyd LNC, Rodriguez E, den Haan JMM, et al. Spatial immune composition of tumor microenvironment in patients with pancreatic cancer. Cancer Immunol Immunother. 2023;72:4385–97.
Google Scholar
Zuo Y, Li B, Gao M, Xiong R, He R, Li N, et al. Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension. Respir Res. 2024;25:147.
Google Scholar
Zong Z, Zou J, Mao R, Ma C, Li N, Wang J, et al. M1 macrophages induce PD-L1 expression in hepatocellular carcinoma cells through IL-1β signaling. Front Immunol. 2019;10:1643.
Google Scholar
Zhong H, Zhou S, Yin S, Qiu Y, Liu B, Yu H. Tumor microenvironment as niche constructed by cancer stem cells: breaking the ecosystem to combat cancer. J Adv Res. 2025;71:279–96.
Google Scholar
Li YR, Fang Y, Lyu Z, Zhu Y, Yang L. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. J Transl Med. 2023;21:686.
Google Scholar
Zhong WZ, Chen KN, Chen C, Gu CD, Wang J, Yang XN, et al. Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer (EMERGING-CTONG 1103): a randomized phase II study. J Clin Oncol. 2019;37:2235–45.
Google Scholar
Zhao L, Tan J, Su Q, Kuang Y. Integration of histopathological images and immunological analysis to predict M2 macrophage infiltration and prognosis in patients with serous ovarian cancer. Front Immunol. 2025;16:1505509.
Google Scholar
Zhang M, Yuan Q, Wang P, Zhang F, Wu D, Bai H, et al. Bone marrow mesenchymal stem cell-derived nanovesicles containing H8 improve hepatic glucose and lipid metabolism and exert ameliorative effects in type 2 diabetes. Int J Nanomedicine. 2024;19:6643–58.
Google Scholar
Yin Y, Yang X, Cheng Z, Wang H, Lei J, Wang D, et al. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation. Front Immunol. 2024;15:1371584.
Google Scholar
Ma S, Qin J, Zhang Y, Luan J, Sun N, Hou G, et al. Disrupting mitochondrial dynamics attenuates ferroptosis and chemotoxicity via upregulating NRF2-mediated FSP1 expression. Cell Rep. 2025;44:116234
Yuan Q, Gu J, Zhang J, Liu S, Wang Q, Tian T, et al. MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization. Cell Rep. 2021;34:108724
Spier I, Holzapfel S, Altmüller J, Zhao B, Horpaopan S, Vogt S, et al. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer. 2015;137:320–31.
Google Scholar
Zuo W, Sun R, Ji Z, Ma G. Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction. Cell Mol Biol Lett. 2023;28:81.
Google Scholar
Zuo Y, Li Q, Xiong Q, Li J, Tang C, Zhang Y, et al. Naringin release from a nano-hydroxyapatite/collagen scaffold promotes osteogenesis and bone tissue reconstruction. Polymers. 2022;14:3260.
Zheng Z, Ma M, Han X, Li X, Huang J, Zhao Y, et al. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma. Acta Biomater. 2023;157:337–51.
Google Scholar
Kim D, Lee JH, Moon H, Seo M, Han H, Yoo H, et al. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model. Theranostics. 2021;11:79–92.
Google Scholar
Zhu L, Zhou X, Gu M, Kim J, Li Y, Ko CJ, et al. Dapl1 controls NFATc2 activation to regulate CD8(+) T cell exhaustion and responses in chronic infection and cancer. Nat Cell Biol. 2022;24:1165–76.
Google Scholar
Zhao W, Zhao J, Li K, Hu Y, Yang D, Tan B, et al. Oncogenic role of the NFATC2/NEDD4/FBP1 axis in cholangiocarcinoma. Lab Invest. 2023;103:100193.
Google Scholar
Yin X, Wang L, Sun Y, Li S, Yu W, Wang S, et al. Identification of cell subpopulation-specific driver genes reveals ideal candidates for renal cell carcinoma immunotherapy. Int J Mol Sci. 2026;27:3467.
Su X, Tan Q, Zheng L, Ding Z. Regulatory T cell dysfunction and exhaustion in uveitis: immunometabol ic mechanisms, microenvironmental drivers, and emerging therapeutic strategies. Front Immunol. 2026;17:1793865.
